Live Breaking News & Updates on International Prognostic Index

Stay updated with breaking news from International prognostic index. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tucidinostat Plus R-CHOP Improves EFS in DLBCL Expressing MYC and BCL2

Tucidinostat plus R-CHOP improved efficacy and was safe in previously untreated DLBCL expressing MYC and BCL2. ....

Weili Zhao , Shanghai Institute Of Hematology , Key Laboratory Of Medical Genomics , International Prognostic Index , National Research Center , Shanghai Institute , State Key Laboratory , Medical Genomics , Translational Medicine , Ruijin Hospital Affiliated , Shanghai Jiao Tong University School ,

Adding Ibrutinib to Chemoimmunotherapy Induction Improves FFS in Younger MCL

The addition of ibrutinib to chemoimmunotherapy induction with ASCT improved rates of failure-free survival in younger patients with mantle cell lymphoma.
....

Martin Dreyling , University Hospital Munich , International Prognostic Index , Department Of Internal Medicine , Prognostic Index , Internal Medicine , Hospital Munich , Ann Arbor ,

How Does Metabolic Tumor Volume Affect Responses to Axi-Cel in LBCL?

The authors say a standard method of assessing metabolic tumor volume would be needed for its use to become widespread. ....

Fred Locke , Frederick Locke , H Lee Moffitt Cancer Center , International Prognostic Index , Moffitt Cancer Center , Moffitt Cancer ,

Follicular Lymphoma - Causes, Symptoms, Diagnosis, Treatment and Prevention

Follicular Lymphoma - Causes, Symptoms, Diagnosis, Treatment and Prevention
medindia.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medindia.net Daily Mail and Mail on Sunday newspapers.

Health Tips , International Prognostic Index , Follicular Lymphoma International Prognostic Index , Computed Tomography ,

Dr Saeed on the Use of Pola-R-CHP in Previously Untreated DLBCL

Hayder Saeed, MD, discusses key takeaways regarding the use of polatuzumab vedotin plus R-CHP in diffuse large B-cell lymphoma. ....

Hayder Saeed , International Prognostic Index , Moffitt Cancer Center , Malignant Hematology , Bridging The Gaps , Hematologic Malignancies ,